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Current laboratory techniques commonly used for the detection of molecular
biomarkers and potential technologies on the horizon
Muhammad Shariq Shaikh, Zeeshan Ansar Ahmed
Madam, Identification of pathogenic mutations and their
products by molecular assays are fundamental not only
for the accurate diagnosis but the probable prognosis and
future counselling. The techniques used range from
conventional mapping of chromosomes to recent
development of next-generation sequencing (NGS), which
has revolutionized the field of molecular diagnostics.
Conventional banding-based chromosomal analysis is a
very useful screening tool which provides information
about all the chromosomes. Chromosomes arrested in
metaphase are examined under the microscope after
staining. Various disorders including congenital anomalies,
developmental delays and malignant disorders are
routinely tested by conventional karyotyping .1 Whereas,
fluorescence in situ hybridization (FISH) utilizes a
fluorophore labeled DNA probe that specifically binds to
nucleic acid sequence of interest. Although FISH technique
is rapid and can be performed on non-dividing (interphase)
cells, it can be used only for known genetic aberrations if
the probe is available.
The discovery of polymerase chain reaction (PCR) in 1980s
was the most significant milestone in history of molecular
diagnostics.2 In a chain reaction, template nucleic acid
copies are increased exponentially within hours. Today,
PCR has become an essential tool in both research and
clinical laboratories. It is widely used for rapid detection
of point mutations, microbial genomes and fusions
transcripts such as BCR-ABL1 in chronic myeloid leukaemia.
In Real-Time PCR, accurate quantification of product during
exponential phase of PCR is provided. The increase in
fluorescence is measured at every cycle and directly
correlates to the amount of PCR product formed. 3
Nucleic acid sequencing, in contrast to PCR identifies
unknown variations in genomic regions of interest. In
Sanger sequencing, PCR amplification is followed by
capillary electrophoresis. The DNA sequence is read from
series of peaks in fluorescence intensity recorded by the
detector. Currently, the most widely used technique,
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capillary electrophoresis based Sanger sequencing is
considered gold standard for mutation analysis particularly
for rare disorders and the genes that do not have common
mutations.
Today, next generation sequencing (NGS) can sequence
whole human genome comprising of three billion base
pairs in one day. This technology has largely superceded
conventional Sanger sequencing particularly in genomic
research. It will inevitably become a part of routine clinical
practice. The 1000 Genomes Project is an international
research effort launched in 2008. It is a detailed catalogue
of human genetic variation that can be accessed by
molecular pathology laboratories to know the sequence
of all human genes.4
Although NGS technologies are rapidly gaining their place,
currently automated Sanger sequence analysis is the most
commonly utilized technique by molecular pathology
laboratories for the identification of disease markers. The
factors that are important to consider in selection of
appropriate assay include volume of patients to be
screened and the gene or allele of interest. FISH and PCR
continue to be widely utilized techniques for known
genetic aberrations.
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